Article
Genetic risk factors for decreased bone mineral accretion in children with asthma receiving multiple oral corticosteroid bursts.
The Journal of allergy and clinical immunology - 1 Nov 2015
Park Heung-Woo, Ge Bing, Tse Szeman, Grundberg Elin, Pastinen Tomi, Kelly H William, Tantisira Kelan G
Abstract excerpt
BACKGROUND: Long-term intermittent oral corticosteroid (OCS) use in children with asthma leads to significant decreases in bone mineral accretion (BMA). OBJECTIVE: We aimed to identify genetic factors influencing OCS dose effects on BMA in children with asthma. METHODS: We first performed a gene-by-OCS interaction genome-wide association study (GWAS) of BMA in 489 white participants in the Childhood Asthma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
